H7 Accelerator
Empowering Healthcare Startups for Strategic Growth and Success
ABOUT H7 ACCELERATOR
H7 BioCapital offers a Once-a-Year virtual accelerator program specifically designed for healthcare companies from Seed to Series A stages. This 4-months long, equity free program features two specialized tracks: Life Science and Medtech, providing a unique opportunity to immerse in Silicon Valley and achieve strategic business objectives.
With most of the portfolios either nearing the closure of their seed round funding, or preparing for their Series A round, this program focus primarily on fundraising and partnership opportunities. Throughout the program, companies will engage in weekly one-on-one meetings with investors mentors from our extensive network of 100+ advisors. They will also pitch both in-person and virtually during Demo Day and other conference organized by H7 and our network partners.
Additionally, the Life Science track emphasizes pre-clinical and clinical development plans and licensing-out opportunities, while the Medtech track concentrates on commercializing or expanding in the U.S. market.
HIGHLIGHTS
Exceptional Quality
100+ Mentors
One-on-one mentor meetings
80+
VCs
Partnering with H7 Accelerator
Fund Raisings
Primary Focus of the Program
12+
Weeks
Virtual program
12+
Workshops
Customized to Cohorts
Free
Consultation
Tax, legal, FDA regulation, AWS credits
OUR ADVISOR NETWORK
One-on-one mentorship
Once you're selected for an accelerator cohort, you'll be part of the H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders.
Venture Capital
Clinical Trial
Marketing/Sales
CRO
Team Recruitment
Business Development
Manufacturing
FDA Regulations
Legal/Patent
Hospital Management
Clinician
Software Development
Finance
Science
Ella Li
Founding Partner
H7 BioCapital
Gary Goldman
Founding Partner
Global Health Impact Fund
Bill Reichert
General Partner
Pegasus Tech Ventures
Ted Hou
Founding Partner
Berkeley Catalyst Fund
Stephan Pflanz
Executive Director
Boehringer-Ingelheim Venture Fund
Neil J. Littman
Managing Director
Bioverge Ventures
INDUSTRIAL FOCUS
Cutting-edge healthcare innovations
Life Science Track
Stage: Angel to Series A
We innovate within the biotech/biopharma sectors. Our focus areas include drug discovery, personalized medicine, synthetic biology, advanced drug delivery systems, and more. Join us in advancing these cutting-edge fields to revolutionize drug development and transform healthcare.
Stage: Angel to Series A
2024 COHORT TIMELINE
Apply now
Applications Open
June 20th
Early Bird Due
July 30th
Applications Due
August 15th
Program Launch
September - December 2024
Demo Day Event
January 2025
PREVIOUS COHORT INTERVIEWS
Cutting-edge healthcare innovations
FAQS
-
Who can apply to H7 Healthcare Acceleration Program?H7 Healthcare Acceleration Program accepts applicants with breakthrough healthcare ideas & technologies: Startups in the stage from Angel to Series A; Industry: life science, biotech, digital medicine (MedTech), medical device, healthcare service; A team with original core technology; Clear direction of industry application.
-
What can you expect from H7Healthcare Accelerator Program?During the three-month program, startups will receive several key entrepreneurial resources including: Mentorship: One-on-one guidance from world-leading physicians, researchers, healthcare professionals and executives at least once a week. Workshop Trainings: Industry experts will lead 12 tailored workshops focusing on healthcare entrepreneurship. Clinician network: A large network of clinician advisors Funding Support: Initial capital injection opportunities provided by our global funding partners to the most promising companies of each cohort. Networks and Events: Networking events will be hosted regularly during each cohort. Teams can meet with our fund partners during Demo Day and Private Investor Meeting. International Growth: Join an international, mentor-filled ecosystem on Healthcare & Biotech Innovation. Alumni will gain direct access to our international partnerships in North America, Europe, and East Asia. Service: Access to Professional service teams including investment bankers, attorneys, auditors and CPAs etc. Continued support: from H7 to provide funding, commercialization, networking and other service after graduation Once you're selected for H7 accelerator cohort, you'll be part of the H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, advisors, and industry leaders.
-
How are applicants selected?Applicants are selected based on team dynamics, experience, and technology & product characteristics. Other factors include the business model, market strategy, potential market size, and total financial considerations. Applicants are evaluated through three screening rounds.
-
How much funding is offered?Each selected team receives mentorship, workshops, co-working space, and becomes a part of the huge network of H7 mentors, investors, healthcare entrepreneurs, global corporate partners. Initial capital injection opportunities are provided by our venture funding partners to the most promising companies of each cohort after the demo day. You will also gain the opportunity to get direct access to our business partners from healthcare corporates and financial investors.
-
Is there any kind of tuition cost for participating in H7 Healthcare Acceleration Program?Early bird applicants accepted into the program will be subject to a program fee of $6,490 (Standard Package) or $3,490 (Essential Package). This fee covers participation in events such as the H7 Healthcare Investment Forum, JPM Innovation Forum, Demo Day, H7 Private investor meetings, and partner events. H7 does not take any equity from accepted companies. For further inquiries, please contact us at info@h7biocapital.com.
-
Are there any specific sectors you invest in?As a healthcare-themed accelerator, we are open to applicants from most areas of healthcare. Accelerator participants will have the potential for up to $1M initial capital injection provided by our funding partners. Our goal is to help our alumins raise money from venture capital or corporate partners after graduation.
-
What happens when the H7 Healthcare Acceleration program ends?H7 Healthcare Acceleration Program is a tailor-made and groundbreaking acceleration program, and is designed to grow startups in life science, biotechnology, medical device and MedTech. Once you're selected for H7 accelerator cohort, you'll be part of the H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. The benefits you'll get from joining H7 community: Alumni will become the member of H7 Innovation Ecosystem and will be invited to participate in our global partners' healthcare events after graduating - Global Health Innovation Network (GHIN), American Association for Precision Medicine (AAPM), World Investors and Entrepreneurs Summit (WISE), Startup.Network, Unicorn Events... We will offer working space at a discounted price in our venture partners, which provide fully-equipped office spaces with benefits in west coasts, aiming to help our alumni quickly start on day one. Selected portfolios from H7 accelerator will be invited to join our global strategic partners events - Unicorn Events, ChinaTrip...to help you develop your business into the global healthcare market in both China and Europe. All companies will have access to our venture partners with higher investment probability. Keep the access to the network of physicians and healthcare innovators through Global Health Innovation Network (GHIN), American Association for Precision Medicine (AAPM), World Investors and Entrepreneurs Summit (WISE), WISE World Investors & Entrepreneurs Society.
-
Can startups participate without moving to the Bay Area?The program will be hybrid with an online presence, physical meet-ups and demo day events. we welcome applications from all over the world. However, we highly recommend you to participate in the program on-site, especially the demo day event. This benefits you because you can take advantage of the numerous opportunities, including the private investor meeting and networking. If you cannot move to the Bay Area for the program, workshops and mentor guidance are available online, but you may miss other benefits.
-
Will H7 sign a nondisclosure agreement?No, we do not sign nondisclosure agreements. No accelerator or venture firm would at this stage.
-
How do I apply for the H7 Healthcare Acceleration Program?If you are a startup entrepreneur, and want to join the program to boost your healthcare idea, please apply here: https://docs.google.com/forms/d/e/1FAIpQLSerdlW73eyp1A7rurH6w0heHnrLFDEen_CvHG5aqtBsXhTBuw/viewform If you a healthcare-relative mentor/advisor/investor/VC funds/corporate/organization/supplier, and want to become a H7 partner, please apply here: https://docs.google.com/forms/d/e/1FAIpQLSfzz7wnwC3J5XD1hML-LTTbHVmysMWtooFFE9DcTOYdUaZ0Sg/viewform
-
Do you have a list of the VC attendees that were at the last demo day?You will have a lot of opportunities to meet with investors during the cohort including the Demo Day. We don’t release a list of our investors, which is always changing. We make no promises, and success is a combination of our network and your hard work building your company.